We are live on ! Find out more
SGAR

iPath Pure Beta Sugar ETN

Delisted

SGAR was delisted on the 11th of April, 2018.

0 hedge funds and large institutions have $0 invested in iPath Pure Beta Sugar ETN in 2013 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 10 (-1)

100% less capital invested

Capital invested by funds: $5K → $0 (-$5K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
Holders Change
-1
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
U
UBS
Switzerland
-$5K
Name Holding Trade Value Shares
Change
Change in
Stake
U
1
UBS
Switzerland
-$5K -146 Closed

SGAR Hedge Fund Activity: Q3 2013 in Review

0 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in iPath Pure Beta Sugar ETN (SGAR) for Q3 2013, worth a combined $0 — down 100% from $5K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of SGAR and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was UBS, exiting entirely with an estimated $5K sold.

  • 0 institutional investors held iPath Pure Beta Sugar ETN (SGAR) as of Q3 2013, down from 1 in Q2 2013.
  • Funds reported $0 of iPath Pure Beta Sugar ETN stock for Q3 2013, down 100% quarter-over-quarter.
  • 0 funds opened new iPath Pure Beta Sugar ETN positions in Q3 2013 and 1 closed out, a net change of -1 holder.
  • The largest iPath Pure Beta Sugar ETN seller in Q3 2013 was UBS, an estimated $5K sold.

Based on aggregated 13F filings for Q3 2013.